AUSTRALIAN CLINICAL LABS LIMITED - Announcements

0.71%

$2.81

Market Cap $551.8M

Healthcare Medical Care

Australian Clinical Labs Limited is a private provider of pathology services. Its... Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ACL	Change of Director's Interest Notice		28/04/22	1.08MB	Share
ACL	Update - Dividend/Distribution - ACL		21/04/22	26.04KB	Share
ACL	Becoming a substantial holder		20/04/22	132.7KB	Share
ACL	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
ACL	Change of Director's Interest Notice		28/02/22	1.08MB	Share
ACL	Establishment of Dividend Reinvestment Plan	PRICE SENSITIVE	24/02/22	1.16MB	Share
ACL	Dividend/Distribution - ACL		24/02/22	25.83KB	Share
ACL	1H22 Investor Presentation	PRICE SENSITIVE	24/02/22	1.8MB	Share
ACL	Media Release - 1H22 Financial Results	PRICE SENSITIVE	24/02/22	863.48KB	Share
ACL	Appendix 4D	PRICE SENSITIVE	24/02/22	35.23KB	Share
ACL	Release of Shares from Voluntary Escrow		15/02/22	350.75KB	Share
ACL	1H22 Financial Results release details		02/02/22	95.74KB	Share
ACL	Letter from Crescent Capital Partners	PRICE SENSITIVE	21/12/21	233.11KB	Share
ACL	Upgrade to 1H FY22 Pro Forma Expectations	PRICE SENSITIVE	21/12/21	384.7KB	Share
ACL	Completion of Medlab Acquisition	PRICE SENSITIVE	20/12/21	345.94KB	Share
ACL	Amended Securities Trading Policy		07/12/21	383.14KB	Share
ACL	Change in substantial holding		26/11/21	102.32KB	Share
ACL	Change of Director's Interest Notice		22/11/21	1.08MB	Share
ACL	Medlab Pathology - Investor Presentation	PRICE SENSITIVE	15/11/21	1.38MB	Share
ACL	Acquisition of Medlab Pathology by ACL	PRICE SENSITIVE	15/11/21	366.18KB	Share
ACL	JobKeeper Report		12/11/21	199.37KB	Share
ACL	Results of 2021 AGM		27/10/21	183.05KB	Share
ACL	2021 AGM addresses and 1H22 trading update	PRICE SENSITIVE	27/10/21	1.27MB	Share
ACL	1H FY22 Updated Profit Guidance	PRICE SENSITIVE	28/09/21	336.95KB	Share
ACL	Notice of Annual General Meeting/Proxy Form		24/09/21	2.24MB	Share
ACL	Appendix 4G		24/09/21	812.04KB	Share
ACL	Annual Report to shareholders		24/09/21	5.85MB	Share
ACL	FY21 financial results investor presentation	PRICE SENSITIVE	26/08/21	2.39MB	Share
ACL	Full Year Statutory Accounts		26/08/21	1.44MB	Share
ACL	Preliminary Final Report	PRICE SENSITIVE	26/08/21	372.33KB	Share
ACL	FY21 financial results investor webinar details		24/08/21	326.35KB	Share
ACL	FY21 financial results release date and 2021 AGM details		16/08/21	333.28KB	Share
ACL	Notification regarding unquoted securities - ACL		16/07/21	25.95KB	Share
ACL	Change in substantial holding		06/07/21	152.07KB	Share
ACL	Upgraded FY21 earnings guidance by 10 to 15%	PRICE SENSITIVE	03/06/21	358.88KB	Share
ACL	Appendix 3G		25/05/21	485.08KB	Share
ACL	Change of Director's Interest Notice		25/05/21	615.22KB	Share
ACL	Becoming a substantial holder		21/05/21	106.5KB	Share
ACL	Confirmation of dispatch of holding statements		20/05/21	440.67KB	Share
ACL	Amended notice - ceasing to be a substantial shareholder		19/05/21	283.92KB	Share
ACL	Top 20 Shareholders and Investor ranges reports		19/05/21	121.32KB	Share
ACL	ASX market release - satisfaction of conditions		19/05/21	94.21KB	Share
ACL	Ceasing to be a substantial holder		19/05/21	114.71KB	Share
ACL	Change in substantial holding		19/05/21	122.23KB	Share
ACL	Change in substantial holding		19/05/21	6.44MB	Share
ACL	Satisfaction of conditions for conditional market		19/05/21	109.52KB	Share
ACL	Becoming a substantial holder		14/05/21	10.87MB	Share
ACL	Initial Director's Interest Notice		14/05/21	237.76KB	Share
ACL	Initial Director's Interest Notice		14/05/21	224.49KB	Share
ACL	Initial Director's Interest Notice		14/05/21	240.49KB	Share
ACL	Initial Director's Interest Notice		14/05/21	237.48KB	Share
ACL	Initial Director's Interest Notice		14/05/21	240.33KB	Share
ACL	Initial Director's Interest Notice		14/05/21	232.3KB	Share
ACL	Initial Director's Interest Notice		14/05/21	239.64KB	Share
ACL	Becoming a substantial holder		14/05/21	192.96KB	Share
ACL	Becoming a substantial holder		14/05/21	133.22KB	Share
ACL	Pre-quotation disclosure		14/05/21	199.07KB	Share
ACL	Indicative top 20 holders		14/05/21	20.72KB	Share
ACL	Indicative distribution schedule		14/05/21	10.77KB	Share
ACL	Securities trading policy		14/05/21	298.18KB	Share
ACL	Corporate governance statement		14/05/21	221.15KB	Share
ACL	Rights plan rules		14/05/21	360.63KB	Share
ACL	SunDoctors 27 December 2020 financial statements		14/05/21	673.41KB	Share
ACL	SunDoctors 28 June 2020 financial statements		14/05/21	525.62KB	Share
ACL	SunDoctors 30 June 2019 financial statements		14/05/21	1.49MB	Share
ACL	SunDoctors 24 June 2018 financial statements		14/05/21	2.84MB	Share
ACL	ACL 31 December 2020 financial statements		14/05/21	527.83KB	Share
ACL	Clinical Laboratories 30 June 2020 financial statements		14/05/21	1.27MB	Share
ACL	Clinical Laboratories 30 June 2019 financial statements		14/05/21	1.66MB	Share
ACL	Clinical Laboratories 30 June 2018 financial statements		14/05/21	5.76MB	Share
ACL	Constitution		14/05/21	594.08KB	Share
ACL	Prospectus		14/05/21	13.19MB	Share
ACL	Appendix 1A and information form and checklist		14/05/21	377.8KB	Share
ACL	Admission to Official List		14/05/21	88.45KB	Share
ACL	Admission and commencement of quotation		12/05/21	141.73KB	Share

ACL Change of Director's Interest Notice
28/04/22		1.08MB	Share
ACL Update - Dividend/Distribution - ACL
21/04/22		26.04KB	Share
ACL Becoming a substantial holder
20/04/22		132.7KB	Share
ACL S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
ACL Change of Director's Interest Notice
28/02/22		1.08MB	Share
ACL Establishment of Dividend Reinvestment Plan
24/02/22	PRICE SENSITIVE	1.16MB	Share
ACL Dividend/Distribution - ACL
24/02/22		25.83KB	Share
ACL 1H22 Investor Presentation
24/02/22	PRICE SENSITIVE	1.8MB	Share
ACL Media Release - 1H22 Financial Results
24/02/22	PRICE SENSITIVE	863.48KB	Share
ACL Appendix 4D
24/02/22	PRICE SENSITIVE	35.23KB	Share
ACL Release of Shares from Voluntary Escrow
15/02/22		350.75KB	Share
ACL 1H22 Financial Results release details
02/02/22		95.74KB	Share
ACL Letter from Crescent Capital Partners
21/12/21	PRICE SENSITIVE	233.11KB	Share
ACL Upgrade to 1H FY22 Pro Forma Expectations
21/12/21	PRICE SENSITIVE	384.7KB	Share
ACL Completion of Medlab Acquisition
20/12/21	PRICE SENSITIVE	345.94KB	Share
ACL Amended Securities Trading Policy
07/12/21		383.14KB	Share
ACL Change in substantial holding
26/11/21		102.32KB	Share
ACL Change of Director's Interest Notice
22/11/21		1.08MB	Share
ACL Medlab Pathology - Investor Presentation
15/11/21	PRICE SENSITIVE	1.38MB	Share
ACL Acquisition of Medlab Pathology by ACL
15/11/21	PRICE SENSITIVE	366.18KB	Share
ACL JobKeeper Report
12/11/21		199.37KB	Share
ACL Results of 2021 AGM
27/10/21		183.05KB	Share
ACL 2021 AGM addresses and 1H22 trading update
27/10/21	PRICE SENSITIVE	1.27MB	Share
ACL 1H FY22 Updated Profit Guidance
28/09/21	PRICE SENSITIVE	336.95KB	Share
ACL Notice of Annual General Meeting/Proxy Form
24/09/21		2.24MB	Share
ACL Appendix 4G
24/09/21		812.04KB	Share
ACL Annual Report to shareholders
24/09/21		5.85MB	Share
ACL FY21 financial results investor presentation
26/08/21	PRICE SENSITIVE	2.39MB	Share
ACL Full Year Statutory Accounts
26/08/21		1.44MB	Share
ACL Preliminary Final Report
26/08/21	PRICE SENSITIVE	372.33KB	Share
ACL FY21 financial results investor webinar details
24/08/21		326.35KB	Share
ACL FY21 financial results release date and 2021 AGM details
16/08/21		333.28KB	Share
ACL Notification regarding unquoted securities - ACL
16/07/21		25.95KB	Share
ACL Change in substantial holding
06/07/21		152.07KB	Share
ACL Upgraded FY21 earnings guidance by 10 to 15%
03/06/21	PRICE SENSITIVE	358.88KB	Share
ACL Appendix 3G
25/05/21		485.08KB	Share
ACL Change of Director's Interest Notice
25/05/21		615.22KB	Share
ACL Becoming a substantial holder
21/05/21		106.5KB	Share
ACL Confirmation of dispatch of holding statements
20/05/21		440.67KB	Share
ACL Amended notice - ceasing to be a substantial shareholder
19/05/21		283.92KB	Share
ACL Top 20 Shareholders and Investor ranges reports
19/05/21		121.32KB	Share
ACL ASX market release - satisfaction of conditions
19/05/21		94.21KB	Share
ACL Ceasing to be a substantial holder
19/05/21		114.71KB	Share
ACL Change in substantial holding
19/05/21		122.23KB	Share
ACL Change in substantial holding
19/05/21		6.44MB	Share
ACL Satisfaction of conditions for conditional market
19/05/21		109.52KB	Share
ACL Becoming a substantial holder
14/05/21		10.87MB	Share
ACL Initial Director's Interest Notice
14/05/21		237.76KB	Share
ACL Initial Director's Interest Notice
14/05/21		224.49KB	Share
ACL Initial Director's Interest Notice
14/05/21		240.49KB	Share
ACL Initial Director's Interest Notice
14/05/21		237.48KB	Share
ACL Initial Director's Interest Notice
14/05/21		240.33KB	Share
ACL Initial Director's Interest Notice
14/05/21		232.3KB	Share
ACL Initial Director's Interest Notice
14/05/21		239.64KB	Share
ACL Becoming a substantial holder
14/05/21		192.96KB	Share
ACL Becoming a substantial holder
14/05/21		133.22KB	Share
ACL Pre-quotation disclosure
14/05/21		199.07KB	Share
ACL Indicative top 20 holders
14/05/21		20.72KB	Share
ACL Indicative distribution schedule
14/05/21		10.77KB	Share
ACL Securities trading policy
14/05/21		298.18KB	Share
ACL Corporate governance statement
14/05/21		221.15KB	Share
ACL Rights plan rules
14/05/21		360.63KB	Share
ACL SunDoctors 27 December 2020 financial statements
14/05/21		673.41KB	Share
ACL SunDoctors 28 June 2020 financial statements
14/05/21		525.62KB	Share
ACL SunDoctors 30 June 2019 financial statements
14/05/21		1.49MB	Share
ACL SunDoctors 24 June 2018 financial statements
14/05/21		2.84MB	Share
ACL ACL 31 December 2020 financial statements
14/05/21		527.83KB	Share
ACL Clinical Laboratories 30 June 2020 financial statements
14/05/21		1.27MB	Share
ACL Clinical Laboratories 30 June 2019 financial statements
14/05/21		1.66MB	Share
ACL Clinical Laboratories 30 June 2018 financial statements
14/05/21		5.76MB	Share
ACL Constitution
14/05/21		594.08KB	Share
ACL Prospectus
14/05/21		13.19MB	Share
ACL Appendix 1A and information form and checklist
14/05/21		377.8KB	Share
ACL Admission to Official List
14/05/21		88.45KB	Share
ACL Admission and commencement of quotation
12/05/21		141.73KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.81		Change -0.020(0.71%)		Mkt cap ! $551.8M

Open	High	Low	Value	Volume
$2.83	$2.84	$2.81	$407.1K	144.4K

Buyers (Bids)

No.	Vol.	Price($)
4	1894	$2.80

Sellers (Offers)

Price($)	Vol.	No.
$2.85	3967	3

View Market Depth

No.	Vol.	Price($)
4	1894	2.800
1	358	2.790
1	5000	2.780
1	30000	2.770
2	14000	2.760

Price($)	Vol.	No.
2.850	967	2
2.870	3525	1
2.880	15000	3
2.890	3000	1
2.900	11739	3

Last trade - 16.10pm 08/08/2025 (20 minute delay)

ACL (ASX) Chart

AUSTRALIAN CLINICAL LABS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available